These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30384338)

  • 1. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1.
    Martin M
    Int J Pharm Compd; 2018; 22(5):401-404. PubMed ID: 30384338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2.
    Martin M
    Int J Pharm Compd; 2018; 22(6):475-478. PubMed ID: 30384348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 4. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies.
    Yoch D
    Int J Pharm Compd; 2017; 21(2):95-102. PubMed ID: 28346203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 6. Implementing United States Pharmacopeia chapter <1163> quality assurance in pharmaceutical compounding, Part 1.
    Allen LV
    Int J Pharm Compd; 2012; 16(2):146-9. PubMed ID: 23050327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP publishes enforceable chapter on sterile compounding.
    Thompson CA
    Am J Health Syst Pharm; 2003 Sep; 60(18):1814, 1817-8, 1822. PubMed ID: 14521028
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality Assurance and Quality Control, Part 2.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compounding parenteral nutrition: reducing the risks.
    Curtis C; Sacks GS
    Nutr Clin Pract; 2009; 24(4):441-6. PubMed ID: 19605798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality Assurance and Quality Control, Part 1.
    Akers MJ
    Int J Pharm Compd; 2015; 19(2):121-4. PubMed ID: 26685493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing United States pharmacopeia chapter <1163> quality assurance in pharmaceutical compounding, part 2: documentation and verification.
    Allen LV
    Int J Pharm Compd; 2012; 16(3):230-4. PubMed ID: 23050301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing United States Pharmacopeia Chapter <1163> quality assurance in pharmaceutical compounding, Part 5: Outsourcing and responsible personnel.
    Allen LV
    Int J Pharm Compd; 2012; 16(6):490-6. PubMed ID: 23259367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blueprint for implementing USP chapter 797 for compounding sterile preparations.
    Kastango ES;
    Am J Health Syst Pharm; 2005 Jun; 62(12):1271-88. PubMed ID: 15947127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA inspections find unsafe practices in compounding pharmacies.
    McCarthy M
    BMJ; 2013 Apr; 346():f2414. PubMed ID: 23592476
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
    Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
    Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding?
    Allen LV
    Int J Pharm Compd; 2019; 23(2):123-130. PubMed ID: 31085778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basics of compounding: implementing United States pharmacopeia chapter <795> pharmaceutical compounding--nonsterile preparations, part 4.
    Allen LV
    Int J Pharm Compd; 2012; 16(1):64-8. PubMed ID: 23050315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of United States Pharmacopeia chapter 797: results of a national survey.
    Candy TA; Schneider PJ; Pedersen CA
    Am J Health Syst Pharm; 2006 Jul; 63(14):1336-43. PubMed ID: 16809754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.